-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Reiterates Market Outperform on Sionna Therapeutics, Maintains $63 Price Target

Benzinga·05/26/2026 13:24:51
Listen to the news
Citizens analyst Jonathan Wolleben reiterates Sionna Therapeutics (NASDAQ:SION) with a Market Outperform and maintains $63 price target.